Volume 8, Issue 4, December 2020, Page: 94-99
Precancerous Cervical Lesion Among Women in Public Hospitals of Addis Ababa, Ethiopia
Tesfay Temesgen, Department of Midwifery, College of Health Science, Dilla University, Dilla, Ethiopia
Girmay Adhena, Department of Reproductive Health, Tigray Regional Health Bureau, Tigray, Ethiopia
Zerihun Figa, Department of Midwifery, College of Health Science, Dilla University, Dilla, Ethiopia
Received: Sep. 1, 2020;       Accepted: Sep. 19, 2020;       Published: Dec. 16, 2020
DOI: 10.11648/j.crj.20200804.15       View        Downloads  
Abstract
Background: Cervical cancer is one of the leading causes of death among women in the world and particularly in Africa. Countries of the glob adopted proven the importance of precancerous lesion screening. However, cervical cancer remains one of the leading causes of cancer morbidity and mortality in sub-Saharan Africa including Ethiopia. This study assessed the prevalence and associated factors of precancerous cervical lesions among women screened at public hospitals in Addis Ababa, Ethiopia. Methods: Institutional based cross-sectional study was conducted among 234 women screened in five public hospitals of Addis Ababa selected by systematic sampling technique. Data were collected by interview using a structured and pre-tested questionnaire. The association of the variable was done by using binary and multiple logistic regressions and a 95% confidence interval were computed to determine the level of significance. Variable with P-value <0.05 was considered as statistically significant. Results: The prevalence of cervical precancerous lesion was 14.1% [(95% CI: (9.4, 18.8)]. Having multiple sexual partners ((AOR = 4.17, 95% CI: (1.3, 13.36)], Being human immune virus positive (HIV) [AOR = 8.16, 95% CI: (2.08, 32.09)], early initiation of sex (before 18 years old) [AOR = 2.34, 95% CI: (1.13, 5.7)], having history of sexual transmitted disease [AOR = 9.97, 95% CI: (2.98, 33.4) and, having a husband with history of sexual transmitted disease [AOR = 4.07, 95% CI: (1.35, 12.3)] were factors significantly associate with the risk of being positive with precancerous cervical lesion. Conclusion: A significant number of women were positive for visual inspection with acetic acid screening (precancerous cervical lesion). Enhancing early cervical cancer screening and addressing community awareness on comprehensive sexual and reproductive health issues tailored to age and culture and early treatment of sexually transmitted diseases are important measures to decrease the problem.
Keywords
Precancerous, Cervical Lesion, Visual Inspection of Acetic Acid, Addis Ababa, Ethiopia
To cite this article
Tesfay Temesgen, Girmay Adhena, Zerihun Figa, Precancerous Cervical Lesion Among Women in Public Hospitals of Addis Ababa, Ethiopia, Cancer Research Journal. Vol. 8, No. 4, 2020, pp. 94-99. doi: 10.11648/j.crj.20200804.15
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Milner DA. Diagnostic Pathology: Infectious Diseases. Elsevier Health Sciences. 2015 (ISBN 9780323400374): p. 40.
[2]
Korde N KS LO. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies". Blood. PMC 3316455 PMID 21441462. May 2011; 117 (21) (doi: 101182/blood-2011-01-270140): 5573-81.
[3]
Kumar V AA, Fausto N, Mitchell RN. Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 2007.
[4]
Cervical Cancer Symptoms, Signs, Causes & Survival Rates, 2018. https://www.emedicinehealth.com/cervical_cancer/article_em.htm.
[5]
Baalbergen AV, Yerney; Stalpers, Lukas; Baalbergen, Astrid. "Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix". Reviews 2013.
[6]
Arbyn M AA, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, von Karsa L. "European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document". Annals of Oncology. 2010.
[7]
WHO. WHO|Cervical cancer. 2018.
[8]
Organization WH. "Fact sheet No. 297: Cancer". Archived from the original on 2014-02-13. February 2014.
[9]
De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013; 31 Suppl 5 (05): F32-F46.
[10]
CIaMW. IARC Cancer Base GLOBOCAN. http://globocaniarcfr. 2012; 1. 0. (Available online).
[11]
Jemal A BF, Forman D, O’Brien M, Ferlay J, Center M, Parkin DM.. Cancer burden in Africa and opportunities for prevention cancer. PubMed. 2012; 118 (18): 4372-84.
[12]
La Vecchia C, Boccia S. Oral contraceptives, human papillomavirus and cervical cancer. Eur J Cancer Prev. 2014; 23.
[13]
Ntekim A. Cervical Cancer in Sub Sahara Africa. 2012.
[14]
Deksissa ZM TF, Ferede HA. Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study. BMC research notes. 2015; 8 (618).
[15]
Tesfahun Hailemariam, Engidawork Mamaye, Goye Orkaido and Mihret Seta. Prevalence of Cervical Cancer and Associated Risk Factors among Women Attending Cervical Cancer Screening and Diagnosis Center at Yirgalem General Hospital, Southern Ethiopia. Journal of Cancer Science & Therapy. 2017.
[16]
Central Statistical Agency Addis Ababa E,. Demographic and Health Survey. ICF International Calverton, Maryland, USA. 2019; March 2012.
[17]
Berraho M, Amarti-Riffi A, El-Mzibri M, Bezad R, Benjaafar N, Benideer A. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study. BMC cancer. 2017; 17 (1): 435-45.
[18]
Makuza JD NS, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. The Pan African medical journal. 2015 (22: 26).
[19]
Kassa RT. Risk factors associated with precancerous cervical lesion among women screened at Marie Stops Ethiopia, Adama town, Ethiopia 2017: a case control study. BMC research notes. 2018; 11 (1): 145.
[20]
Jolly PE, Mthethwa-Hleta S, Padilla LA, Pettis J, Winston S, Akinyemiju TF, et al. Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. BMC public health. 2017; 17 (1): 218.
[21]
Teame H, Addissie A, Ayele W, Hirpa S, Gebremariam A, Gebreheat G, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study. PloS one. 2018; 13 (1): e0191506-e.
Browse journals by subject